DATROWAY Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic TNBC Who Are Not Candidates ...
The FDA accepted a supplemental biologics license application and granted priority review for Datroway for adults ...
Verywell Health on MSN
What you need to know about triple-negative breast cancer with chemo resistance
Medically reviewed by Marla Anderson, MD Key Takeaways Triple-negative breast cancer is aggressive and often resists ...
A Purdue University team has discovered a new therapeutic target for triple-negative breast cancer. The research, led by Kyle ...
AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for DATROWAY® (datopotamab deruxtecan-dlnk) has been accepted and granted Priority Review in the US for the treatment ...
By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative ...
A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.
The National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines in Oncology to include ...
Strides in cancer research are happening in Dallas. Most recently, breast cancer doctors say they may have found a new way to fight one of the most devastating subtypes of cancer. UT Southwestern ...
Our stories are reviewed by medical professionals to ensure you get the most accurate and useful information about your health and wellness. For more information, visit our medical review board. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results